m+Medelevator.RU
← Поиск публикаций
Journal of affective disorders · 2026

PDE2A is involved in negative emotional behaviors via the cAMP-PKA signaling pathway in the SPS&S model.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Jiang Baoying, Wu Lanxia, Zhang Guohui, Fu Yuzi, Lu Yining, Wei Peili, Lin Han, Zhu Guohui, Nie Jiwei, Sun Lin

Аннотация

BACKGROUND: Post-traumatic stress disorder (PTSD) is characterized by negative affective symptoms, including anxiety, depression, anhedonia, and fear. The molecular mechanisms underlying these symptoms remain poorly understood. Phosphodiesterase 2A (PDE2A), a regulator of cyclic adenosine monophosphate (cAMP) signaling, has been implicated in neuropsychiatric disorders.

OBJECTIVE: This study aimed to investigate the role of the PDE2A-cAMP-protein kinase A (PKA) signaling pathway in negative emotional behaviors induced by traumatic stress.

METHODS: Transcriptomic datasets were analyzed to identify differentially expressed genes and enriched pathways. A rat PTSD model was established using single prolonged stress combined with foot shocks (SPS&S). Behavioral tests were performed, and PDE2A-cAMP-PKA signaling alterations in the amygdala were examined. The effects of PDE2A inhibitor Hcyb1 and the PKA inhibitor H89 were evaluated.

RESULTS: Bioinformatics analysis identified PDE2A as a hub gene associated with PTSD, with significant enrichment of the cAMP signaling pathway. SPS&S rats exhibited anxiety-, depression-like behaviors, and anhedonia, accompanied by increased PDE2A expression and reduced cAMP and phosphorylated PKA (p-PKA) levels in the amygdala. Hcyb1 treatment alleviated behavioral deficits, decreased PDE2A expression, and restored cAMP and p-PKA signaling. H89 blocked p-PKA activation and partially reversed the behavioral benefits of Hcyb1.

CONCLUSION: These findings suggest that amygdala PDE2A-cAMP-PKA signaling is associated with negative emotional behaviors in the SPS&S model. PDE2A inhibition may ameliorate behavioral deficits through PKA-related signaling. However, the peripheral blood transcriptomic data, lack of direct PDE2A activity and cAMP/cGMP measurements, and limited biochemical validation constrain mechanistic interpretation. Further studies using brain-derived datasets and comprehensive biochemical approaches are warranted.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты